EPHB4 and neoplasm: Two large studies investigated the expression of EPHB4 through IHC and real-time RT-PCR in CC tissue samples and reported that high EPHB4 expression correlated with adverse clinical disease stage, larger tumor size, LN metastasis, high MVD, and poor patient OS [75,76].